pegfilgrastim biosimilar (NAL Pharma)

非格司亭生物类似药 (NAL Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug Namepegfilgrastim biosimilar (NAL Pharma)

Drug Alias Name非格司亭生物仿制药 (NAL Pharma)PEG-GCSF - NAL Pharma培非格司亭生物仿制药 (NAL Pharma)NAL-3760

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionHaematopoiesis stimulantsColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNal Pharma

China Registration ClassN/A

Active CompaniesNal Pharma

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

ATC CodeL03AA13